In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Generative AI will continue to be a driving force in innovation, but its future must be sustainable by design.

Pennsylvanians will benefit from $100 billion in energy- and artificial intelligence-related investments to energize the nation's growing AI economy.

Historian Niall Ferguson warns against unlimited access to AI tools for those under 25, calling it a disaster for brain development.

RXRX is scaling its AI-driven drug discovery technology through billion-dollar pharma deals and strategic tech alliances.

EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched the EVERSANA AI Accelerator, a dedicated center of excellence (COE) focused on the ...

Unlike Elon Musk's brain-computer interface, Synchron's doesn't require open-skull surgery, and it has an OpenAI chatbot ...

The Trump administration should push back against foreign governments enacting policies that undermine American tech ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary care clinicians make diagnoses.